Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm

Diagnostic Cytopathology

Volumn 37, Issue 10, 2009, Pages 783-785

  Trimboli, Pierpaolo ^a   Condorelli, Emma ^a   Catania, Antonio ^b   Sorrenti, Salvatore ^b  

^a Piazza San Bartolomeo All'Isola 21   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN TUMOR; CANCER DIAGNOSIS; CANCER RISK; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; LETTER; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID NODULE;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; RISK FACTORS; THYROID NODULE;

EID: 70349307200     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21136     Document Type: Letter

References (27)

1. Gharib H, Goellner JR. Fine-needle aspiration biopsy of thyroid: An appraisal. Ann Intern Med 1993;118:282-289. (Pubitemid 23046388)
2. Baloch ZW, Sack MJ, Yu GH, et al. Fine-needle aspiration of thyroid: an institutional experience. Thyroid 1998;8:565-569. (Pubitemid 28354907)
3. Bronner MP, LiVolsi VA. Oxyfilic (Ashanazy/Hürthle cell) tumors of the thyroid gland: Microscopic features predict biologic behaviour. Surg Pathol 1988;1:137-150.
4. Carcangiu ML, Bianchi S, Savino D, et al. Follicular Hürthle cell tumors of the thyroid. Cancer 1991;68:1944-1953.
5. Giorgadze T, Rossi ED, Fadda G, et al. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocitic features" denote increased risk of malignancy? Diagn Cytopathol 2004;31:307-312.
6. Lopez-Penabad L, Chiu AC, Hoff AO, et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 2003; 97:1186-1194. (Pubitemid 36237303)
7. Kushchayeva Y, Duh QY, Kebebew E, et al. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hürthle cell or follicular thyroid cancer. Am J Surg 2008; 195:457-462.
8. Pu RT, Yang J, Wasserman PG, et al. Does Hürthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol 2006;34: 330-334.
9. Bahar G, Braslavsky D, Shpitzer T, et al. The cytological and clinical value of the thyroid follicular lesion. Am J Otoryngol 2003; 24:217-220.
10. Davis NL, Gordon M, Germann E, Robins RE, McGregor GI. Clinical parameters predictive of malignancy of thyroid follicular neoplasms. Am J Surg 1991;161:567-569.
11. Rago T, Di Coscio G, Basolo F, et al. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hürthle cell thyroid lesions: Results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) 2007; 66:13-20. (Pubitemid 44952489)
12. Trimboli P, Ulisse S, D'Alò M, et al. Analysis of clinical, ultrasound and colour flow-doppler characteristics in predicting malignancy in follicular thyroid neoplasms. Clin Endocrinol (Oxf) 2008;69:342-344. (Pubitemid 352009010)
13. Sorrenti S, Trimboli P, Catania A, Ulisse S, De Antoni E, D'Armiento M. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm. Thyroid 2009;19:355-360.
14. Schlinkert RT, van Heerden JA, Goellner JR, et al. Factors that predict malignant thyroid lesion when fine needle aspiration is suspicious for follicular neoplasm. Mayo Clin Proc 1997;72:913-916. (Pubitemid 27459424)
15. Baloch ZW, Fleisher S, LiVolsi VA, et al. Diagnosis of follicular neoplasm: A gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2001;26:41-44.
16. Kim ES, Nam-Goong IS, Gong G, et al. Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of so-called "follicular neoplasm". Korean J Intern Med 2003;18:94-97.
17. Banks ND, Kowalski J, Tsai HL, et al. A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 2008;18:933-941.
18. Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: Relevance of iodine intake, sex, and multinodularity. Am J Med 1992;93:363-369.
19. Boelaert K, Horacek J, Holder RL, et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006; 91:4295-4301. (Pubitemid 44833401)
20. Tuttle RM, Lemar H, Burch HB. Clinical features associated with an increased risk thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998;8:377-383. (Pubitemid 28252418)
21. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Eng J Med 1985;312: 601-604. (Pubitemid 15133674)
22. Boi F, Lai ML, Marziani B, et al. High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol 2005;153:637-642. (Pubitemid 41672409)
23. Rago T, Di Coscio G, Ugolini C, et al. Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had thyroidectomy. Clin Endocrinol (Oxf) 2007;67:363-369. (Pubitemid 47283831)
24. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941-1946. (Pubitemid 34521470)
25. Paramo JC, Mesko T. Age, tumor size, and in-office ultrasonography are predictive parameters of malignancy in follicular neoplasms of the thyroid. Endocr Pract 2008;14:447-451.
26. De Nicola H, Szejnfeld J, Logullo AF, et al. Flow pattern and vascular index as predictors of malignancy risk in thyroid follicular neoplasm. J Ultrasound Med 2005;24:897-904. (Pubitemid 40885172)
27. Trimboli P, Sorrenti S. Low value of color flow-doppler in predicting malignancy of thyroid follicular neoplasms. Diagn Cytopathol 2009;37:391-392.